부산대학교 도서관

Alarcón-Veleiro, C. ; López-Calvo, I. ; Berjawi, L. ; Lucio-Gallego, S. ; Mato-Basalo, R. ; Quindos-Varela, M. ; Lesta-Mellid, R. ; Santamarina-Caínzos, I. ; Varela-Rodríguez, S. ; Fraga, M. ; Quintela, M. ; Vizoso-Vázquez, A. ; Arufe, MC ; Fafián-Labora, J.

In Biomedicine & Pharmacotherapy June 2025 187

Sarda, M. Sol Fernandez; Mellid, Lourdes Baez; Brizuela, Paula; Dicembrino, Manuela; Giugno, Hilda; Castanos, Claudio

ARCHIVOS ARGENTINOS DE PEDIATRIA; MAR 16 2023, 5p.

Monteagudo, María ; Calsina, Bruna ; Salazar-Hidalgo, Milton E. ; Martínez-Montes, Ángel M. ; Piñeiro-Yáñez, Elena ; Caleiras, Eduardo ; Martín, Maria Carmen ; Rodríguez-Perales, Sandra ; Letón, Rocío ; Gil, Eduardo ; Buffet, Alexandre ; Burnichon, Nelly ; Fernández-Sanromán, Ángel ; Díaz-Talavera, Alberto ; Mellid, Sara ; Arroba, Ester ; Reglero, Clara ; Martínez-Puente, Natalia ; Roncador, Giovanna ; del Olmo, Maria Isabel ; Corrales, Pedro José Pinés ; Oliveira, Cristina Lamas ; Álvarez-Escolá, Cristina ; Gutiérrez, María Calatayud ; López-Fernández, Adrià ; García, Nuria Palacios ; Regojo, Rita María ; Díaz, Luis Robles ; Laorden, Nuria Romero ; Guadarrama, Oscar Sanz ; Bechmann, Nicole ; Beuschlein, Felix ; Canu, Letizia ; Eisenhofer, Graeme ; Fassnacht, Martin ; Nölting, Svenja ; Quinkler, Marcus ; Rapizzi, Elena ; Remde, Hanna ; Timmers, Henri J. ; Favier, Judith ; Gimenez-Roqueplo, Anne-Paule ; Rodriguez-Antona, Cristina ; Currás-Freixes, Maria ; Al-Shahrour, Fatima ; Cascón, Alberto ; Leandro-García, Luis J. ; Montero-Conde, Cristina ; Robledo, Mercedes

In Best Practice & Research Clinical Endocrinology & Metabolism

Piroli, Gerardo G. ; Manuel, Allison M. ; McCain, Richard S. ; Smith, Holland H. ; Ozohanics, Oliver ; Mellid, Sara ; Cox, J. Hunter ; Cotham, William E. ; Walla, Michael D. ; Cascón, Alberto ; Ambrus, Attila ; Frizzell, Norma

In Redox Biology November 2023 67

Sara Mellid; Eduardo Gil; Rocío Letón; Eduardo Caleiras; Emiliano Honrado; Susan Richter; Nuria Palacios; Marcos Lahera; Juan C. Galofré; Adriá López-Fernández; Maria Calatayud; Aura D. Herrera-Martínez; María A. Galvez; Xavier Matias-Guiu; Milagros Balbín; Esther Korpershoek; Eugénie S. Lim; Francesca Maletta; Sofia Lider; Stephanie M. J. Fliedner; Nicole Bechmann; Graeme Eisenhofer; Letizia Canu; Elena Rapizzi; Irina Bancos; Mercedes Robledo; Alberto Cascón

Front Endocrinol (Lausanne)
Dadun. Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
WOS:000932433800001
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
Repositori Obert UdL
Frontiers in Endocrinology, Vol 13 (2023)

Mellid, Sara; Gil, Eduardo; Letón, Rocío; Caleiras, Eduardo; Honrado, Emiliano; Richter, Susan; Palacios, Nuria; Lahera, Marcos; Galofré, Juan C; López-Fernández, Adriá; Calatayud, Maria; Herrera-Martínez, Aura D; Galvez, María A; Matias-Guiu, Xavier; Balbín, Milagros; Korpershoek, Esther; Lim, Eugénie S; Maletta, Francesca; Lider, Sofia; Fliedner, Stephanie M J; Bechmann, Nicole; Eisenhofer, Graeme; Canu, Letizia; Rapizzi, Elena; Bancos, Irina; Robledo Batanero, Mercedes; Cascon Soriano, Alberto

Repisalud
Instituto de Salud Carlos III (ISCIII)

Martínez-Puente N; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.; Ruz-Caracuel I; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Biomedical Research Networking Center on Cancer (CIBERONC), Institute of Health Carlos III, Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Pian-Arias H; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Vega-Corral Z; Histopathology Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Letón R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Radu R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Berrizbeitia M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Mellid S; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Reglero C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Salazar-Hidalgo ME; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Arroba E; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Díaz-Talavera A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.; Marazuela M; Department of Endocrinology and Nutrition, Hospital Universitario La Princesa, Madrid, Spain.; Benito-Berlinches A; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; González-García I; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Campos-Mena S; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Lozano-Escario MD; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Guadalix S; Department of Endocrinology, Clínica Universidad de Navarra, Madrid, Spain.; Calatayud M; Department of Endocrinology and Nutrition, Hospital Universitario 12 de Octubre, Madrid, Spain.; Pérez-Campos A; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lahera M; Department of Endocrinology and Nutrition, Hospital Universitario La Princesa, Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.; Galofré JC; Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain.; Currás-Freixes M; Familial Cancer Clinical Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Caleiras EJ; Histopathology Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Valderrabano P; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain. Electronic address: mrobledo@cnio.es.; Montero-Conde C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain. Electronic address: cmontero@cnio.es.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE

Gomez-Randulfe Rodriguez, M.I.; Lesta Mellid, R.; Parajó Vázquez, I.; Silva Diaz, S.; Alonso de Castro, B.; Quindós, M.

ESMO Open. 8(1)

Mellid S; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Martínez-Montes ÁM; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Arenas A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Jiménez S; Monoclonal Antibodies Core Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Monteagudo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Letón R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Radu R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Álvarez-Díaz R; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Arroba E; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Diaz-Talavera A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Martínez-Puente N; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Álvarez-Escolá C; Department of Endocrinology, La Paz University Hospital, 28046 Madrid, Spain.; Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL-ONCOBELL, L'Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.; Balbín M; Molecular Oncology Laboratory, Instituto Universitario de Oncología del Principado de Asturias, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.; Al-Shahrour F; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Rodriguez-Antona C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Pharmacogenomics and Tumor Biomarkers Group, Institute for Biomedical Research Sols-Morreale (CSIC-UAM), 28029 Madrid, Spain.; Montero-Conde C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Honrado E; Anatomical Pathology Service, Hospital of León, 24071 León, Spain.; Soria-Tristán M; Oncology Department, Hospital Universitario de Getafe, 28905 Getafe, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.

Publisher: Elsevier B.V. on behalf of KeAi Communications Co. Ltd Country of Publication: Netherlands NLM ID: 101635967 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3042 (Electronic) Linking ISSN: 23523042 NLM ISO Abbreviation: Genes Dis Subsets: PubMed not MEDLINE

de Castro, B. Alonso; Cobo, S.; MaLillyos, J. Perez; Rendo, C. Reboredo; Lopez, M. E. Perez; Castillo, O.; Sirenko, V.; Aguirre, A.; Blasco, P.; Calvo, L.; Pena, M. Alonso; Mellid, R. Lesta; Varela, M. Quindos; Galvan, P.; Torres, E. Sanfeliu; Nieves, P. Saavedra; Prat, A.; Braso-Maristany, F.; Antolin-Novoa, S.

ANNALS OF ONCOLOGY; SEP 2025, 36 2p. Supplement: 2

Mellid S; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; García F; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Díaz-Talavera A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Martínez-Montes ÁM; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Gil E; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Calsina B; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Monteagudo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Letón R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Roldán-Romero JM; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Santos M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Lanillos J; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Valdivia C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martínez-Puente N; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; de Nicolás-Hernández J; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Jiménez S; Monoclonal Antibodies Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Pérez-Martínez M; Confocal Microscopy Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Honrado E; Anatomical Pathology Service, Hospital of León, León, Castilla y León, Spain.; Coloma J; Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Cerezo A; CNIO-Lilly Cell Signalling and Immunometabolism Section, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Santiveri CM; Spectroscopy and Nuclear Magnetic Resonance Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), L'Hospitalet, Barcelona, Spain.; Campos-Olivas R; Spectroscopy and Nuclear Magnetic Resonance Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Montero-Conde C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Muñoz J; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Cell Signaling and Clinical Proteomics Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE

Calsina B; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. bcalsina@cnio.es.; Piñeiro-Yáñez E; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martínez-Montes ÁM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Caleiras E; Histopathology Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Fernández-Sanromán Á; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Monteagudo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Torres-Pérez R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Bioinformatics for Genomics and Proteomics, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.; Fustero-Torre C; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Pulgarín-Alfaro M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Gil E; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Letón R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Jiménez S; Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; García-Martín S; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martin MC; Molecular Cytogenetics and Genome Engineering Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Roldán-Romero JM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Lanillos J; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Mellid S; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Santos M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Díaz-Talavera A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Rubio Á; Genomics Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; González P; Histopathology Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hernando B; Computational Oncology Group, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Bechmann N; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Dona M; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Calatayud M; Department of Endocrinology, 12 de Octubre University Hospital, Madrid, Spain.; Guadalix S; Department of Endocrinology, 12 de Octubre University Hospital, Madrid, Spain.; Álvarez-Escolá C; Department of Endocrinology, La Paz University Hospital, Madrid, Spain.; Regojo RM; Department of Pathology, La Paz University Hospital, Madrid, Spain.; Aller J; Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain.; Del Olmo-Garcia MI; Department of Endocrinology and Nutrition, University Hospital La Fe, Valencia, Spain.; López-Fernández A; Department of Medical Oncology, Vall d'Hebrón Hospital, Barcelona, Spain.; Fliedner SMJ; Neuroendocrine Oncology and Metabolism, Medical Department I, Center of Brain, Behavior, and Metabolism, University Medical Center Schleswig-Holstein Lübeck, Lübeck, Germany.; Rapizzi E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.; Beuschlein F; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.; Klinik für Endokrinologie Diabetologie und Klinische Ernährung, Universitätsspital Zürich (USZ) und Universität Zürich (UZH), Zürich, Switzerland.; Quinkler M; Endocrinology in Charlottenburg Stuttgarter Platz 1, Berlin, Germany.; Toledo RA; Gastrointestinal and Endocrine Tumors, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Mannelli M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Timmers HJ; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Eisenhofer G; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Rodríguez-Perales S; Molecular Cytogenetics and Genome Engineering Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Domínguez O; Genomics Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Macintyre G; Computational Oncology Group, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Currás-Freixes M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Department of Endocrinology, Clínica Universidad de Navarra, Madrid, Spain.; Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Montero-Conde C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Roncador G; Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; García-García JF; Department of Pathology, MD Anderson Cancer Center, Madrid, Spain.; Pacak K; Section of Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.; Al-Shahrour F; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. mrobledo@cnio.es.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain. mrobledo@cnio.es.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Gerardo G. Piroli; Allison M. Manuel; Richard S. McCain; Holland H. Smith; Oliver Ozohanics; Sara Mellid; William E. Cotham; Michael D. Walla; Alberto Cascón; Attila Ambrus; Norma Frizzell

M.I. Gomez-Randulfe Rodriguez; S. Silva Díaz; R. Lesta Mellid; M. Quindos Varela; B. Alonso de Castro; I. Parajó Vázquez; R. Garcia Campelo

Annals of Oncology. 33:S1391

Roldán-Romero JM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Valdivia C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Santos M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Lanillos J; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Maroto P; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Anguera G; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Calsina B; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martinez-Montes A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Monteagudo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Mellid S; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Montero-Conde C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Roncador G; Monoclonal Antibodies Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Coloma J; Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.; Rodriguez-Antona C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Gutierrez-Gutierrez, Sara; Mellid-Carballal, Rocio; Csaba, Noemi; Garcia-Fuentes, Marcos

Journal of Functional Biomaterials. August, 2025, Vol. 16 Issue 8

B Grana Suarez; A. Molina; J. Prato; C. Czestokowa; C. Conde; C Reboredo Rendo; M. Quindos; E. Perez; R Lesta Mellid; P. Cordeiro; I. Gomez-Randulfe; S. Antolin; L. Calvo

Annals of Oncology. 30:v414

Cascón A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Calsina B; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Monteagudo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Mellid S; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Díaz-Talavera A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Currás-Freixes M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Publisher: BioScientifica Country of Publication: England NLM ID: 8902617 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6813 (Electronic) Linking ISSN: 09525041 NLM ISO Abbreviation: J Mol Endocrinol Subsets: MEDLINE

Monteagudo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; PhD Program in Neuroscience, Autonoma de Madrid University, 28029 Madrid, Spain.; Martínez P; Telomeres and telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Martínez-Montes ÁM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Calsina B; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Pulgarín-Alfaro M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Díaz-Talavera A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Mellid S; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Letón R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Gil E; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Pérez-Martínez M; Confocal Microscopy Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Megías D; Confocal Microscopy Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Torres-Ruiz R; Molecular Citogenetic, Unit Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Rodriguez-Perales S; Molecular Citogenetic, Unit Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; González P; Histopathology Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Caleiras E; Histopathology Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Jiménez-Villa S; Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Roncador G; Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Álvarez-Escolá C; Department of Endocrinology, La Paz University Hospital, 28046 Madrid, Spain.; Regojo RM; Department of Pathology La Paz University Hospital, 28046 Madrid, Spain.; Calatayud M; Department of Endocrinology, 12 de Octubre University Hospital, 28041 Madrid, Spain.; Guadalix S; Department of Endocrinology, 12 de Octubre University Hospital, 28041 Madrid, Spain.; Currás-Freixes M; Department of Endocrinology, Clínica Universidad de Navarra, 28027 Madrid, Spain.; Rapizzi E; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.; Canu L; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.; Nölting S; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336 Munich, Germany.; Remde H; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, 97070 Würzburg, Germany.; Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, 97070 Würzburg, Germany.; Comprehensive Cancer Center, Mainfranken University of Würzburg, 97070 Würzburg, Germany.; Bechmann N; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01069 Dresden, Germany.; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01069 Dresden, Germany.; Eisenhofer G; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01069 Dresden, Germany.; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01069 Dresden, Germany.; Mannelli M; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.; Beuschlein F; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336 Munich, Germany.; Klinik für Endokrinologie Diabetologie und Klinische Ernährung, Universitätsspital Zürich, 8091 Zürich, Switzerland.; Quinkler M; Endocrinology in Charlottenburg Stuttgarter Platz 1, 10627 Berlin, Germany.; Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Blasco MA; Telomeres and telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Montero-Conde C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Portilla Y; Department of Immunology and Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Mellid S; Department of Immunology and Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Paradela A; Proteomics Facility, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Ramos-Fernández A; Proteomics Facility, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Daviu N; Department of Immunology and Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Sanz-Ortega L; Department of Immunology and Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Pérez-Yagüe S; Department of Immunology and Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.; Morales MP; Department of Energy, Environment and Health, Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Sor Juana Inés de la Cruz 3, Madrid 28049, Spain.; Barber DF; Department of Immunology and Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Madrid 28049, Spain.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE